MedTrace Logo

Cortisol Regulation in Polycystic Ovary Syndrome (PCOS)

NCT00694759 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 37

Last updated 2019-09-09

No results posted yet for this study

Summary

The purpose of this study is to determine if insulin resistance (how well the body uses insulin and clears sugar) can affect cortisol levels in normal healthy women and women with polycystic ovary syndrome of all body weights.

Conditions

  • Polycystic Ovary Syndrome

Interventions

DRUG

pioglitazone

30 mg for 2 weeks, then 45 mg daily

DRUG

metformin

500mg twice daily for 1 week, then 1000 mg twice daily

DRUG

placebo

capsule twice daily

Sponsors & Collaborators

  • Oregon Health and Science University

    lead OTHER

Principal Investigators

  • Bethany J. Klopfenstein, MD · Oregon Health and Science University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-10-31
Primary Completion
2011-06-30
Completion
2011-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00694759 on ClinicalTrials.gov